Pfizer Offloads Its Last 7% Stake In Consumer Health Haleon For Over $3 Billion
Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's ...
FTSE 100 Live 19 March: Santander set to close 95 branches, Pfizer makes £2.5bn Haleon exit
FTSE 100 Live Wednesday Pfizer completes Haleon exitSantander to close 95 branchesM&G shares rise on results beat ...
Pfizer offloads final shares in Sensodyne maker Haleon
Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US ...
Pfizer Wraps Up Haleon Exit With $3.3 Billion Stake Sale
Pfizer Inc. raised about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, culminating ...
Sensodyne toothpaste maker Haleon now an independent company after Pfizer sells stake
Shares in the consumer health group - originally a joint venture between Pfizer and GSK - are up nearly a fifth since it ...
City snapshot: Pfizer completes £2.5bn Haleon exit
Pfizer still owns about 7.3% of the company making it the largest shareholder. GSK sold its remaining stake in May last year.
Pfizer exits Haleon with £2.4bn stake sale
Pfizer has fully exited its investment in UK-listed pharma group Haleon, selling off its remaining 7.3% stake for £2.5bn.
Hosted on MSN21d
Haleon CEO: We're relatively low-exposed to tariffs
Haleon CEO Brian McNamara says his company is not as exposed as peers to tariff risks, as the consumer healthcare company reports full-year results Gene Hackman, Oscar-winning star of 'Hoosiers ...
Haleon plc (NYSE:HLN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 27, 2025 Haleon plc misses on earnings expectations. Reported EPS is $0.05 EPS, expectations were $25.25. Jo Russell: Good morning, everyone. Welcome to ...